← Back to Search

Regenerative Medicine

Regenerative Surgery for Post-Mastectomy Breast Deformity

N/A
Recruiting
Research Sponsored by BioAesthetics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial tested the effectiveness of a donor graft to help heal wounds from nipple-areolar complex reconstruction surgery.

Who is the study for?
This trial is for women aged 18-65 who've had a bilateral mastectomy and autologous breast reconstruction at least 3 months ago, without radiation therapy. Participants must not have NAC tattoos, agree to sleep on their back, avoid aspirin, alcohol, caffeine until healed, and use contraception if of childbearing potential.Check my eligibility
What is being tested?
The study tests the healing response after reconstructing the nipple-areolar complex (NAC) using a decellularized donor graft. It aims to assess wound healing quality and patient satisfaction with this regenerative surgery technique post-mastectomy.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks may include infection at the surgical site, immune reaction to the graft material or poor cosmetic outcome. Patients' experiences can vary based on individual health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Healing of the nipple (VAS=Visual Analog Scale) dehiscence
Healing of the nipple (VAS=Visual Analog Scale) epithelialization
Healing of the nipple (VAS=Visual Analog Scale) granulation
+4 more
Secondary outcome measures
Evaluate patient satisfaction and well-being preoperatively and serially
Nipple projection
Vascularization by presence of bleeding
Other outcome measures
Nipple sensitivity up to 12 months
Operative time in minutes
Physician Preference and Impressions

Trial Design

1Treatment groups
Experimental Treatment
Group I: Implant of acellular NAC graftExperimental Treatment1 Intervention
The implantation of the NAC acellular graft for regenerative nipple areolar complex

Find a Location

Who is running the clinical trial?

BioAestheticsLead Sponsor
Roger Morgan, MDStudy ChairMedSurgPI, LLC

Media Library

Regenerative post mastectomy surgery (Regenerative Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT05484934 — N/A
Post-Mastectomy Breast Deformity Clinical Trial 2023: Regenerative post mastectomy surgery Highlights & Side Effects. Trial Name: NCT05484934 — N/A
Regenerative post mastectomy surgery (Regenerative Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05484934 — N/A
Post-Mastectomy Breast Deformity Research Study Groups: Implant of acellular NAC graft

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an open enrollment period for this clinical trial?

"Affirmative. According to the records on clinicaltrials.gov, this examination is still open for enrollments with a post date of September 21st 2022 and an update on October 13th 2022. The study aims to recruit 36 participants at 1 location."

Answered by AI

Is the research initiative accepting volunteers over two decades old?

"For adults aged 18 to 65, this clinical trial serves as an opportunity for medical research. In contrast, there are 49 studies specifically targeting minors and 77 trials tailored toward seniors over the age of 65."

Answered by AI

To what extent is this clinical trial open to participants?

"Affirmative. Clinicaltrials.gov verifies that this clinical trial has been actively seeking participants since its posting date on September 21st 2022, with the last edit occuring October 13th 2022. 36 prospective patients are being recruited from a single medical centre for this study."

Answered by AI

Are there particular cohorts that are more ideal for enrollment in this clinical investigation?

"This clinical trial seeks 36 participants aged 18 to 65 that have undergone a bilateral mastectomy and autologous breast reconstruction at least 3 months prior. Furthermore, female patients must take measures to avoid pregnancy for one month before the grafting procedure as well as during recovery. These could include abstinence or any double combination of: intrauterine device (IUD), male/female condom, diaphragm, sponge, and cervical cap etc. Additionally all subjects must be able to comprehend the study procedures thoroughly in order to provide informed consent according their HIPAA rights if applicable."

Answered by AI
~5 spots leftby Aug 2024